Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Cryo Cell International (CCEL) Accumulated Depreciation & Amortization (2016 - 2025)

Cryo Cell International's Accumulated Depreciation & Amortization history spans 15 years, with the latest figure at $6.6 million for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $6.6 million for Q4 2025, up 16.34% from a year ago — trailing twelve months through Nov 2025 was $6.6 million (up 16.34% YoY), and the annual figure for FY2025 was $6.6 million, up 16.34%.
  • Accumulated Depreciation & Amortization for Q4 2025 was $6.6 million at Cryo Cell International, up from $5.6 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $8.1 million in Q4 2023 to a low of $5.6 million in Q4 2024.
  • The 5-year median for Accumulated Depreciation & Amortization is $7.5 million (2021), against an average of $7.1 million.
  • The sharpest move saw Accumulated Depreciation & Amortization tumbled 30.62% in 2024, then increased 16.34% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $7.5 million in 2021, then rose by 3.79% to $7.8 million in 2022, then grew by 4.17% to $8.1 million in 2023, then tumbled by 30.62% to $5.6 million in 2024, then increased by 16.34% to $6.6 million in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $6.6 million, $5.6 million, and $8.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.